ScholarWorks@Gachon: Kim, Jong Hoon

Detailed Information

Kim, Jong Hoon (김종훈)

College of Medicine (Department of Medicine)

Research Area

Tel 032-460-2696
Homepage

ResearcherID ORCiD Scopus Google Scholar ID ResearchGate

Keyword

Schizophrenia:9||positron emission tomography:8||Positron emission tomography:7||Magnetic resonance imaging:3||Serotonin transporter:3||[F18]fallypride:3||schizophrenia:3||Major depression:3||[C11]DASB:3||Metabotropic glutamate receptor5:3||Functional magnetic resonance imaging:2||depressive symptoms:2||major depressive disorder:2||PET:2||Tolerability:2||functional magnetic resonance imaging:2||Efficacy:2||heart rate variability:2||Antipsychotics:2||Adiponectin:2||Data Systems:1||Deep learning:1||Depression:1||Diffusion tensor imaging:1||DnCNN:1||Doctor:1||Dopamine:1||Escitalopram:1||Excitement symptom:1||Extrastriatal D2/3 receptor:1||FDG:1||Facial emotional expression:1||Factor structure:1||Firstepisode psychosis:1||Fivefactor model:1||Fractional anisotropy:1||Frontotemporal:1||Glucose metabolism:1||Glutamate:1||Gonogo task:1||Highresolution PET:1||Inflammatory biomarkers:1||Insight:1||Insula:1||Internet of Things:1||Knockout:1||Korean population:1||Leptin:1||MRI and magnetic resonance spectroscopy:1||MRS:1||Metabolic syndrome:1||Mosaic augmentation:1||Motor Skills:1||NMDA:1||Norepinephrine:1||PANSS:1||Paliperidone extendedrelease:1||Porous silicon:1||Positronemission tomography:1||Prefrontal cortex:1||Primary health care.:1||Principal component analysis:1||QOL:1||Quality of life:1||Raphe nucleus:1||Schizoaffective disorder:1||Selftranscendence:1||Serotonin transporter availability:1||Sex difference:1||Suicide:1||Surfaceenhanced Raman scattering:1||Tablets:1||Thalamus:1||Tongue cancer:1||Topdown:1||Translocator protein:1||Young adult:1||[11 C]ABP688:1||[11C]ABP688:1||[11C]DASB:1||[11C]PK11195:1||[C11] ABP688:1||[C11]ABP688:1||[F18]FDG:1||aggression:1||antioestrogen treatment:1||antipsychotics:1||aripiprazole:1||breast cancer:1||character traits:1||clozapine:1||cognitive insight:1||convolutional neural network:1||depression:1||dopamine receptor:1||early response:1||efficacy:1||firstepisode psychosis:1||flavonoid therapy:1||generalized anxiety disorder:1||healthy subjects:1||heart rate dynamics:1||high resolution:1||hybrid imaging:1||impulsivity:1||internalized stigma:1||local linear fitting:1||mGluR5:1||magnetic resonance imaging:1||major depression:1||metaanalysis:1||metabotropic glutamate receptor5:1||molecular imaging:1||nanoscale silver:1||neuroinflammation:1||nonlinear complexity measures:1||oestrogen receptor status:1||parasympathetic modulation:1||plasma dopamine:1||psychiatric disorders:1||quality of life:1||raclopride:1||randomized controlled trial:1||reconstruction:1||safety:1||selfreflectiveness:1||selftranscendence trait:1||serotonin:1||serotonin transporter:1||silicon nanowires:1||social avoidance:1||striatal subdivisions:1||subjective cognitive deficits:1||subjective quality of life:1||subjective restlessness:1||surfaceenhancedRaman scattering:1||translocator protein:1||treatment response:1||의사:1||일차의료.:1||자살:1||3 receptor:1||자살에 대한 태도:1||5HT2A receptor:1||Abdominal and liver fat:1||Agdeposited:1||Alcohol dependence:1||Antidepressant:1||Asenapine:1||Attention system:1||Attitude toward suicide:1||Auditory hallucinations:1||Automatism:1||Bottomup:1||Breast cancer:1||Butyricicoccus pullicaecorum:1||C11 DASB:1||C11 MDL100907:1||Class imbalance:1||Curriculum learning:1||D2:1||D2/3 receptor:1||

STATISTICS: Total View :4,137,406; Today View :5,153

RSS_1.0 RSS_2.0 ATOM_1.0

1342, Seongnam-daero, Sujeong-gu, Seongnam-si, Gyeonggi-do, Republic of Korea(13120)031-750-5114

Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.

Detailed Information

Keyword

BROWSE